ReOxy is a new breathing therapy medical device, that treats a patient with individually dosed levels of reduced-oxygen (hypoxic) gas mixtures throughout the procedure.
The main objective to be achieved with use of the ReOxy device is short and long-term adaptive response at systemic, organic, tissue and cellular levels. These compensatory mechanisms of adaptation have been scientifically proven to effectively treat cardiovascular and metabolic diseases.
ReOxy uses Self Regulated Treatment (SRT) technology. SRT-technology relies upon the principle of biological feedback, where patient bodily reaction define therapeutic parameters and controls them throughout the whole treatment session.